Implementation of A Patient Centered Self-Management Program for Patients With Type 2 Diabetes

Not Applicable

Completed

• Conditions: Type 2 Diabetes

• Registration Number: NCT02497170
• Lead Sponsor: Rutgers, The State University of New Jersey

Brief Summary

Translational study based on the American Association of Diabetes Educators 7 behaviors to manage Type 2 diabetes

Detailed Description

The Primary Investigator will meet with patients that attend routine visits for Diabetes 2 in the primary care office on a monthly basis to set behavior goals. Behavior goals will be set by patient's choice of 4 out of 7 of the AADE7 recommendations. The goals are health eating, being active, monitoring,taking medications, problem solving, healthy coping, and reducing risk. Once the goal is chosen, the PI and patient will make a plan to address the goals on a monthly basis for four months. There will be pre and post questionnaires that will evaluate diabetes knowledge and self-efficacy. There will also be a pre and post measure of the patient's Hemoglobin A1c which is a measurement that helps determine the extent of glycemic control over a three-month period.

The goal of the study is to determine if translation of the AADE7 behavioral goals into the primary care setting will make a difference in diabetes knowledge, self efficacy, and Hemoglobin A1c.

Study Timeline

• Study First Submitted: 2015-07-10
• Study First Submitted QC: 2015-07-13
• Study First Posted: 2015-07-14
• Study Start: 2015-09
• Primary Completion: 2016-02
• Study Completion: 2016-02
• Status Verified: 2016-03
• Last Update Submitted: 2016-03-10
• Last Update Posted: 2016-03-11

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 9

Inclusion Criteria

• Patients over 18 with Hemoglobin A1c 7 mmol/mol or higher will be included in the study
• Patients willing to attend minimum of 4 monthly appointments for diabetes treatment
• Patients who give written consent to participate

Exclusion Criteria

• Patients below age 18, children are not treated in the facility for type 2 diabetes
• Patients who attend less than 4 monthly appointments for diabetes,
• Patients who do no give written consent to participate

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Primary Outcome Measures

Name	Time	Method
Hemoglobin A1c	4 months	Pre and Post Differences

Trial Locations

Locations (1)

Melissa Souza; 🇺🇸 Somerdale, New Jersey, United States